Vagal nerve stimulator use during pregnancy for treatment of refractory seizure disorder

Obstetrics and Gynecology

Volumn 115, Issue 2 SUPPL. 2 PART. 2, 2010, Pages 417-419

  Houser, Molly V ^a   Hennessy, Mark D ^a   Howard, Bobby C ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPROST TROMETAMOL; MISOPROSTOL; OXYTOCIN; PHENYTOIN;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; IMPLANT; NERVE STIMULATION; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY; PRENATAL CARE; PRIMIGRAVIDA; PRIORITY JOURNAL; SEIZURE; TREATMENT DURATION; UTERINE ATONY; VAGAL NERVE STIMULATOR; VAGUS NERVE;

ANTICONVULSANTS; COMBINED MODALITY THERAPY; EPILEPSY, TONIC-CLONIC; FEMALE; HUMANS; PHENYTOIN; PREGNANCY; PREGNANCY COMPLICATIONS; TREATMENT OUTCOME; VAGUS NERVE STIMULATION; YOUNG ADULT;

EID: 77649240391     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181bd1a8b     Document Type: Article

References (8)

1. Creasy R, Resnik R, Iams J, Lockwood C, Moore T, editors. Creasy Resnik's Maternal-fetal medicine: principles and practice. 6th ed. Philadelphia (PA):Elsevier; 2009.
2. Battino D, Tomson T. Management of epilepsy during pregnancy. Drugs 2007;67:2727-2746
3. Perucca E. Birth defects after prenatal exposure to antiepileptic drugs. Lancet Neurol 2005;4:781-786
4. Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth GS, French JA. Management issues for women with epilepsy-focus on pregnancy (an evidence-based review): II. Ter-atogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2009;50: 1237-1246
5. Husain MM, Stegman D, Trevino K. Pregnancy and delivery while receiving vagus nerve stimulation for the treatment of major depression: a case report. Ann Gen Psychiatry 2005;4:16.
6. Karceski S, Mullin P. Expanding therapeutic options: devices and the treatment of refractory epilepsy. Curr Neurol Neurosci Rep 2004;4:321-328
7. Sucholeiki R, Alsaadi TM, Morris GL 3rd, Ulmer JL, Biswal B, Mueller WM. fMRI in patients implanted with a vagal nerve stimulator. Seizure 2002;11:157-162
8. Tanganelli P, Ferrero S, Colotto P, Regesta G. Vagus nerve stimulation for treatment of medically intractable seizures. Evaluation of long-term outcome. Clin Neurol Neurosurg 2002;105:9-13.